PURPOSE OF REVIEW This year marks 10 years from the publication of the clinical consensus statement on pediatric chronic rhinosinusitis (CRS). Balloon sinuplasty did not meet criteria for consensus at that time because there was insufficient evidence on its efficacy and safety. The purpose of this review is to summarize the current evidence on balloon sinuplasty treatment for pediatric CRS. RECENT FINDINGS Balloon sinuplasty is not a cost-effective measure compared to adenoidectomy and endoscopic sinus surgery (ESS). In the pediatric population, benefits include short operative time, reduced tissue manipulation, and potential for decreased antibiotic courses. Alternatively, balloon dilation has increased equipment costs and there is a lack of robust prospective data that fully elucidates balloon sinuplasty's role in the management of pediatric CRS. SUMMARY Pediatric otolaryngologists should continue to perform first-line adenoidectomy and consider ESS based on imaging and other validated clinical scoring systems. Balloon sinuplasty has not yet been proven as an effective treatment for pediatric CRS and further large-scale investigations are required to overcome its lack of cost-effectiveness.

中文翻译：

---

球囊鼻窦成形术治疗小儿慢性鼻窦炎的评价。


审查目的 今年是小儿慢性鼻-鼻窦炎 （CRS） 临床共识声明发表 10 周年。球囊鼻窦成形术当时不符合共识标准，因为没有足够的证据证明其有效性和安全性。本综述的目的是总结目前关于球囊鼻窦成形术治疗儿科 CRS 的证据。最近的发现 与腺样体切除术和内窥镜鼻窦手术 （ESS） 相比，球囊鼻窦成形术不是一种具有成本效益的措施。在儿科人群中，益处包括手术时间短、减少组织操作以及可能减少抗生素疗程。或者，球囊扩张增加了设备成本，并且缺乏可靠的前瞻性数据来充分阐明球囊鼻窦成形术在儿科 CRS 管理中的作用。摘要 小儿耳鼻喉科医生应继续进行一线腺样体切除术，并根据影像学和其他经过验证的临床评分系统考虑 ESS。球囊鼻窦成形术尚未被证明是治疗儿科 CRS 的有效方法，需要进一步的大规模研究以克服其缺乏成本效益的问题。